The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study.
 
Tae Won Kim
Employment - Asan Medical Center
Honoraria - AstraZeneca; Merck Serono; Pfizer
 
Jeeyun Lee
No Relationships to Disclose
 
Sang Joon Shin
No Relationships to Disclose
 
Jin-Soo Kim
Stock and Other Ownership Interests - Chong Kun Dang Pharmaceutical; DAEHWA Pharmaceutical
Honoraria - Boehringer Ingelheim; CJ Healthcare; Lilly; Merck
Consulting or Advisory Role - CJ Healthcare; DAEHWA Pharmaceutical; Lilly
Research Funding - Alpha Biopharma; ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Chong Kun Dang Pharmaceutical; CJ Healthcare; Five Prime Therapeutics; Hanmi; Lilly; Merck; Novotech; Ono Pharmaceutical; Pfizer; Sanofi; Yuhan
Expert Testimony - CJ Healthcare
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Yu Jung Kim
No Relationships to Disclose
 
Hye Sook Han
No Relationships to Disclose
 
Soo Jung Lee
No Relationships to Disclose
 
Hyeong-Seok Lim
No Relationships to Disclose
 
Yoon-hee Hong
Employment - Hanmi
 
Young Su Noh
Employment - Hanmi
 
Yujung Kyoung
Employment - Hanmi
 
Oakpil Han
Employment - Hanmi
 
Jiyeon Yoon
Employment - Hanmi
 
Jeong Ah Lim
Employment - Hanmi
 
Suk Ran Kim
Employment - Hanmi